This story has been updated to include information from a conference call to discuss Quidel's earnings.

NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its second quarter revenues rose 11 percent year over year due primarily to sales of infectious disease and women's health products.

Revenues for the three months ended June 30 increased to $39.1 million from $34.9 million in Q2 2015, above the average analysts' estimate of $38 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.